Obinutuzumab-Based Immunochemotherapy Prolongs Progression-Free Survival
   and Time to Next Anti-Lymphoma Treatment in Patients with Previously
   Untreated Follicular Lymphoma: Four-Year Results from the Phase III
   GALLIUM Study

Titel:: Obinutuzumab-Based Immunochemotherapy Prolongs Progression-Free Survival and Time to Next Anti-Lymphoma Treatment in Patients with Previously Untreated Follicular Lymphoma: Four-Year Results from the Phase III GALLIUM Study
Dokumenttyp:: Meeting Abstract
Autor(en):: Townsend, William; Buske, Christian; Cartron, Guillaume; Cunningham, David; Dyer, Martin J. S.; Gribben, John G.; Hess, Georg; Ishikawa, Takayuki; Keller, Ulrich; Kneba, Michael; Malladi, Ram; Neidhart, Jeffrey D.; Rusconi, Chiara; Zhu, Jun; Catalani, Olivier; Knapp, Andrea; Zeuner, Harald; Herold, Michael; Hiddemann, Wolfgang; Marcus, Robert
Zeitschriftentitel:: Blood
Jahr:: 2018
Band / Volume:: 132
Volltext / DOI:: doi:10.1182/blood-2018-99-115167
Print-ISSN:: 0006-4971
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: